Antibody responses of the first wave of survivors infected with SARS-CoV-2 1 year ago

J Med Virol. 2022 May;94(5):1770-1772. doi: 10.1002/jmv.27551. Epub 2022 Jan 5.

Authors

Lu He¹, Cheng Zeng², Yuyang Zeng³, Wanzhou Xu⁴, Ying Li¹, Xiaojie Xie¹, Wei Xu¹, Hongmiao Xia¹, Fengjuan Tang¹, Shiqi Tang¹, Lijuan Xu¹, Changzheng Chen³

Affiliations

¹ Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.
² Department of Orthopedics, Affiliated Hospital of Hebei University, Baoding, China.
³ Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
⁴ Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

No abstract available

Keywords: SARS coronavirus; coronavirus; epidemiology; immunity/immunization; infection; virus classification.

Publication types

Letter

MeSH terms

Antibodies, Viral / blood*
Antibody Formation*
COVID-19* / immunology
Humans
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Survivors

Substances

Antibodies, Viral
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2

Grants and funding

Wuhan Health Committee (grants no. EX20B03)